← Browse by Condition
Medical Condition
tumor solid
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, EARLY_Phase 1
NCT06484556 Phase 1
Recruiting
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Enrollment
9 pts
Location
China
Sponsor
Tao Zhang
NCT06431529 EARLY_Phase 1
Recruiting
A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors
Enrollment
6 pts
Location
China
Sponsor
JIANG LONGWEI
NCT05661461 Phase 1
Recruiting
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Enrollment
28 pts
Location
United States
Sponsor
Aadi Bioscience, Inc.